Sodium Bicarbonate Administration in TCA Toxicity
Administer hypertonic sodium bicarbonate as intravenous boluses of 50-150 mEq (1-3 mEq/kg) for adults or 1-3 mEq/kg for children, titrated to resolution of QRS prolongation and hypotension, with repeat boluses every 5-10 minutes as needed. 1
Formulation and Initial Dosing
Use hypertonic solutions: 8.4% sodium bicarbonate (1 mEq/mL) in adults and 4.2% (0.5 mEq/mL) in children 1. The standard adult dose is 50-150 mEq (typically 1-2 ampules of 50 mEq each), while pediatric dosing is 1-3 mEq/kg 1.
For life-threatening cardiotoxicity with QRS widening >100-120 ms, hypotension, or ventricular dysrhythmias, give the initial bolus rapidly and repeat every 5-10 minutes until clinical improvement 1, 2.
Titration Strategy
Titrate to clinical endpoints, not arbitrary pH targets:
- Primary goal: Resolution of QRS prolongation and restoration of blood pressure 1
- Monitor: QRS duration on continuous ECG, blood pressure, serum pH, sodium, and potassium 1
The 2023 AHA guidelines note that whether to follow initial boluses with a continuous infusion versus additional boluses as needed remains unsettled 1. Recent data from Australian toxicology units suggests that dual therapy with sodium bicarbonate boluses plus mechanical ventilation (if intubated) achieves serum alkalinization most effectively and produces faster QRS narrowing 3.
Safety Parameters and Monitoring
Critical safety thresholds to avoid iatrogenic harm 1:
- Serum sodium: Do not exceed 150-155 mEq/L
- Serum pH: Do not exceed 7.50-7.55
- Monitor potassium closely: Hypertonic bicarbonate causes hypokalemia requiring aggressive replacement 1
Each 100 mmol bolus of sodium bicarbonate increases serum sodium by approximately 2.5 mmol/L 3. The maximum recommended cumulative dose is <400 mmol (approximately 6 mmol/kg) to avoid dangerous hypernatremia 3.
Continuous Infusion Preparation (If Used)
If transitioning to continuous infusion after initial boluses, prepare a 150 mEq/L solution and infuse at 1-3 mL/kg/hour 1. However, the evidence does not clearly favor continuous infusion over repeated boluses as needed 1.
Duration of Therapy
Continue treatment until sustained clinical improvement, not based on pharmacokinetic calculations. In massive overdoses, TCA elimination half-lives can be dramatically prolonged (up to 184 hours versus the normal 14-51 hours) due to saturable kinetics, delayed absorption, and enterohepatic recirculation 4. Some patients require sodium bicarbonate infusions for up to 14 days in severe poisonings 4.
Mechanism and Rationale
Sodium bicarbonate works through dual mechanisms: sodium loading overcomes sodium channel blockade, while alkalemia further enhances sodium channel function 1, 5. Animal studies suggest sodium loading may be the more important factor 5, but the combination provides additive benefit 1.
Common Pitfalls
- Don't delay treatment waiting for laboratory confirmation—treat based on clinical presentation (QRS >100-120 ms, hypotension, dysrhythmias) 1, 6
- Don't use sodium bicarbonate for isolated CNS toxicity (seizures alone)—this requires benzodiazepines, not bicarbonate 7
- Don't assume normal TCA pharmacokinetics in massive overdoses—clinical endpoints (QRS duration, hemodynamics) guide therapy duration, not calculated half-lives 4
- Don't forget potassium replacement—hypokalemia from bicarbonate therapy can worsen dysrhythmias 1
Second-Line Therapies
If sodium bicarbonate fails, consider 1:
- Hypertonic saline (3% NaCl) for additional sodium loading
- Lidocaine for persistent wide-complex tachycardia (second-line after bicarbonate)
- VA-ECMO for refractory cardiogenic shock
- Intravenous lipid emulsion only as last resort after all other therapies fail